Keybank National Association OH lowered its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 265,695 shares of the pharmacy operator’s stock after selling 8,694 shares during the period. Keybank National Association OH’s holdings in Walgreens Boots Alliance were worth $14,696,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the business. Sageworth Trust Co purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $27,000. Quest Capital Management Inc. ADV purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $31,000. First Interstate Bank boosted its stake in shares of Walgreens Boots Alliance by 228.1% in the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 422 shares during the last quarter. TRUE Private Wealth Advisors purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $38,000. Finally, Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth approximately $38,000. Institutional investors and hedge funds own 60.60% of the company’s stock.
A number of equities analysts have recently weighed in on WBA shares. ValuEngine upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, October 30th. JPMorgan Chase & Co. downgraded Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $73.00 to $63.00 in a research note on Wednesday, October 23rd. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Cleveland Research reiterated a “hold” rating on shares of Walgreens Boots Alliance in a research note on Monday, September 9th. Finally, Deutsche Bank began coverage on Walgreens Boots Alliance in a research note on Thursday, September 12th. They issued a “sell” rating on the stock. Five analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $61.35.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.73% of the company’s stock.
WBA stock traded up $0.74 during midday trading on Friday, reaching $59.41. 215,058 shares of the company’s stock traded hands, compared to its average volume of 6,292,109. The company has a 50-day moving average price of $55.01 and a two-hundred day moving average price of $53.51. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.36 and a current ratio of 0.73. Walgreens Boots Alliance Inc has a 52 week low of $49.03 and a 52 week high of $86.31. The firm has a market capitalization of $54.63 billion, a PE ratio of 9.92, a price-to-earnings-growth ratio of 1.53 and a beta of 0.87.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The business had revenue of $33.95 billion for the quarter, compared to analysts’ expectations of $33.88 billion. During the same quarter in the previous year, the firm posted $1.48 EPS. The business’s revenue for the quarter was up 1.5% compared to the same quarter last year. As a group, analysts predict that Walgreens Boots Alliance Inc will post 5.93 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.458 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.83 dividend on an annualized basis and a yield of 3.08%. Walgreens Boots Alliance’s payout ratio is 30.55%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: How to find the components of the quick ratio
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.